How do you manage a newly diagnosed locally advanced ER+/HER2- breast cancer with synchronous diagnosis of metastatic melanoma?

When dealing with two concurrent malignancies you need to look at the overall prognosis for both of them to determine the best course of action. If the melanoma was oligometastatic and resected to NED or had a complete durable response to immunotherapy then one could consider more aggressive curativ...